Taiwan grants EUA to local vaccine maker's COVID-19 vaccine

Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)